APA (7th ed.) Citation

Z, X., W, Z., Q, X., W, H., Y, C., H, Q., . . . SC, N. (2026). Synbiotics and antioxidants synergistically attenuate disease progression in metabolic dysfunction-associated steatotic liver disease. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 201, 119656. https://doi.org/10.1016/j.biopha.2026.119656

Chicago Style (17th ed.) Citation

Z, Xu, et al. "Synbiotics and Antioxidants Synergistically Attenuate Disease Progression in Metabolic Dysfunction-associated Steatotic Liver Disease." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 201 (2026): 119656. https://doi.org/10.1016/j.biopha.2026.119656.

MLA (9th ed.) Citation

Z, Xu, et al. "Synbiotics and Antioxidants Synergistically Attenuate Disease Progression in Metabolic Dysfunction-associated Steatotic Liver Disease." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 201, 2026, p. 119656, https://doi.org/10.1016/j.biopha.2026.119656.